Wang DS, Ren C, Li SS, Fong WP, et al. Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial. PLoS Med 2024;21:e1004389.
PMID: 38728364